Hemostasis and Thrombosis Research and Clinical Trials
Researchers at Lifespan are actively studying hemophilia and other types of bleeding and clotting disorders.
See current clinical trials:
We are the only hemophilia center in the state and one of only four centers in the New England region to offer a 340B program, which allows us to deliver factor directly to our patients. Our enhanced services are unique and provide our patients with additional benefits they may not receive at other hospitals and health care providers.
Conditions We Treat
We evaluate and treat conditions such as:
- Hemophilia A
- Hemophilia B
- Von Willebrand disease
- Platelet disorders
- Other factor deficiencies
- Deep vein thrombosis
- Pulmonary embolus
- Clotting disorders, including Factor V Leiden, MTHFR gene mutations, protein C and S deficiencies, and prothrombin gene mutations
Our staff consists of highly qualified medical providers in both the pediatric and adult settings who are experienced in the care of bleeding and clotting disorders. We are proud of our affiliations with the National Hemophilia Foundation, the Centers for Disease Control and Prevention, the Maternal and Child Health Bureau and the American Society of Hematology.
The Hemostasis and Thrombosis Center conducts research to advance treatment for bleeding and clotting disorders. We are an affiliate of the American Thrombosis and Hemostasis Network and are a participating center in My Life, Our Future, a nationwide campaign for progress in hemophilia treatment.
If you are a researcher and would like more information about research opportunities, please visit the Lifespan research administration website.